| Abbreviations, acronyms & symbols | ||||
|---|---|---|---|---|
| ACCP | = American College of Chest Physicians | MI | = Myocardial infarction | |
| ACS | = Acute coronary syndrome | MRI | = Magnetic resonance imaging | |
| AF | = Atrial fibrillation | NOACs | = Non-vitamin K antagonists oral anticoagulants | |
| CABG | = Coronary artery bypass graft | PAD | = Peripheral arterial disease | |
| CAD | = Coronary artery disease | PE | = Pulmonary embolism | |
| CDC | = Centers for Disease Control and Prevention | PESI | = Pulmonary embolism severity index | |
| CHD | = Coronary heart disease | RCT | = Randomized controlled trials | |
| CUS | = Compression ultrasonography | RR | = Relative risk | |
| CVD | = Cardiovascular disease | RV | = Right ventricular | |
| DVT | = Deep vein thrombosis | sPESI | = Simplified pulmonary embolism severity index | |
| HFS | = Hip fracture surgery | THA | = Total hip arthroplasty | |
| HT | = Hypertension | TIA | = Transient ischemic attack | |
| IL | = Interleukin | TKA | = Total knee arthroplasty | |
| LMWH | = Low-molecular-weight heparin | TTE | = Transthoracic echocardiography | |
| MCP | = Monocyte chemotactic protein | UFH | = Unfractionated heparin | |
| MDCT | = Multi-detector computed tomographic | VKAs | = Vitamin K antagonists | |
| METHRO | = Melagatran for Thrombin Inhibition in Orthopaedic Surgery |
VTE | = Venous thromboembolism | |